Protein Expression Analysis in Uterine Cervical Cancer for Potential Targets in Treatment

Pathol Oncol Res. 2019 Apr;25(2):493-501. doi: 10.1007/s12253-018-0401-0. Epub 2018 Mar 12.

Abstract

Specific markers in lesions of the human uterine cervix cancer (UCC) are still needed for prognostic, diagnostic and/or therapeutic purposes. In this study we evaluated key molecules at protein level between normal epithelium, cervical intraepithelial neoplasia (CIN1-3) and invasive cancer of a group of molecules previously reported at mRNA level. For that purpose, human formalin-fixed paraffin embedded tissue microarrays (TMAs) were constructed containing 205 Mexican tissue core specimens. Immunohistochemistry and quantitative analysis of histological staining was performed against twenty-two distinct proteins for each core and the processing platform ImageJ. In the progression of the disease we found key statistical differences for the proteins SEL1, Notch3 and SOCS3. High expressions of SEL1L, Notch3 and SOCS3 have potential value to increase the prognostic of UCC in combination with markers such as p16INK4a. This study identified key drivers in cervical carcinogenesis that should be evaluated for the development of UCC therapies.

Keywords: Immunohistochemistry; Notch3; SEL1L; SOCS3; Tissue microarray; Uterine cervical cancer.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Female
  • Humans
  • Proteins / metabolism*
  • Receptor, Notch3 / biosynthesis*
  • Suppressor of Cytokine Signaling 3 Protein / biosynthesis*
  • Uterine Cervical Dysplasia / metabolism*
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Neoplasms / metabolism*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • NOTCH3 protein, human
  • Proteins
  • Receptor, Notch3
  • SEL1L protein, human
  • SOCS3 protein, human
  • Suppressor of Cytokine Signaling 3 Protein

Grants and funding